"Supreme Court's Battle Over Abortion Pills Sparks Controversy"
The US Supreme Court is set to hear arguments in a case regarding the abortion pill mifepristone, with opponents citing studies to argue for limiting its access, while the FDA maintains its safety. The plaintiffs claim that the studies show increased risk, but the research group behind the studies disagrees, stating that the conclusions support easier access to the medication. The case could have broader implications for federal regulatory authority over drug safety, and a ruling is expected by the end of June.